Immunologix's Unattributed - II Round

Immunologix raised a round of funding on July 20, 2011.

Immunologix is a human antibody development company founded on a proprietary technology that transforms naive B-cells into fully human monoclonal antibodies targeting any antigen. In October 2011, Im…

Articles about Immunologix's Unattributed - II Round: